January 24, 2013 at 10:02 AM EST
Wilex Selects GeneDiagnostics to Distribute Cancer Test in China
Wilex Inc., a US maker of diagnostic tests, has engaged GeneDiagnostics as its exclusive distributor for the company’s serum HER-2/neu ELISA test in China. Based in Hangzhou, GeneDiagnostics is a CRO/service provider. The biomarker test is used to monitor patients with metastatic breast cancer. It is approved for US and European use; GeneDiagnostics will be responsible for obtaining its China approval. Financial terms of the agreement were not disclosed. More details.... Share this with colleagues: // //  
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here